Pliant Therapeutics
Discovering, developing and commercializing treatments for fibrotic diseases. Learn more
Launch date
Employees
Market cap
$730m
Enterprise valuation
$353m (Public information from Sep 2024)
Share price
$12.62 PLRX
San Francisco California (HQ)
Authorizing premium user...